# TREPROSTINIL
> **ANDA211574** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC GLOBAL · Approved 2021-02-11
## Drug
- **FDA Application Number:** ANDA211574
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TREPROSTINIL
- **Generic name:** TREPROSTINIL
- **Active ingredients:** TREPROSTINIL
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC GLOBAL
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2021-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211574)
---
*AI Analytics · CC0 1.0*